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Abstract
Rates of marijuana use among detained youths are exceptionally high. Research suggests a 
cannabis withdrawal syndrome is valid and clinically significant; however, these studies have 
mostly been conducted in highly controlled laboratory settings with treatment-seeking, White 
adults. The present study analyzed archival data to explore the magnitude of cannabis withdrawal 
symptoms within a diverse sample of detained adolescents while controlling for tobacco use and 
investigating the impact of race on symptom reports. Adolescents recruited from a juvenile 
correctional facility (N=93) completed a background questionnaire and the Marijuana Withdrawal 
Checklist. Analyses revealed a significant main effect for level of tobacco use on severity of 
irritability, and for level of marijuana use on severity of craving to smoke marijuana and strange/
wild dreams. Furthermore, a significant main effect for race was found with Black adolescents 
reporting lower withdrawal discomfort scores and experiencing less severe depressed mood, 
difficulty sleeping, nervousness/anxiety, and strange/wild dreams. Although exploratory, these 
findings may have significant clinical implications for providers in juvenile detention facilities, 
allowing the execution of proper medical and/or behavioral interventions to assist adolescents 
presenting with problematic cannabis and/or tobacco withdrawal.
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1. Introduction
Marijuana is the most commonly used illicit substance among adolescents, with 6.8% of 12 
to 17 year-olds reporting use in the past month (SAMHSA, 2007). Rates of marijuana use 
are exceptionally high among incarcerated youth. A study involving 1,300 juvenile 
offenders reported a marijuana lifetime prevalence use rate of 85%, with 57% using 
marijuana in the past 6 months (Mulvey, Schubert, & Chassin, 2010). Moreover, 
McClelland, Teplin, & Abram (2004) found the rate of marijuana use among male juvenile 
detainees to be 77.3% during the past 6 months, with 90.2% reporting lifetime use.
Although not yet recognized by the Diagnostic and Statistical Manual, Fourth Edition, Text 
Revision (DSM-IV-TR), several studies have produced results suggesting that a cannabis 
withdrawal syndrome is both valid and clinically significant as experienced by many heavy 
cannabis users (Budney & Hughes, 2006; Budney, Hughes, Moore, & Vandrey, 2004; 
Budney, Novy, & Hughes, 1999; Levin et al., 2010). Symptoms commonly reported in 
cannabis withdrawal studies include: Anger/aggression, anxiety/nervousness, appetite 
change, depressed mood, irritability, restlessness, sleep difficulty, somatic complaints, 
strange dreams, and weight change (Vandrey, Budney, Moore, & Hughes, 2005). 
Furthermore, cannabis withdrawal symptoms have been found to be similar in magnitude 
and time course to those experienced during tobacco withdrawal, a widely accepted and 
firmly established withdrawal syndrome (Vandrey, Budney, Moore et al., 2005).
Most of what is known about cannabis withdrawal has been produced from studies with 
adult cannabis users. Vandrey, Budney, Kamon, & Stanger (2005) assessed the prevalence 
and magnitude of cannabis withdrawal symptoms among adolescent treatment seekers. The 
most commonly reported symptoms included craving to smoke marijuana, depressed mood, 
irritability, restlessness, sleep difficulty, increased anger, decreased appetite, increased 
aggression, nervousness/anxiety, and headache. Furthermore, adolescents meeting criteria 
for cannabis dependence reported significantly higher withdrawal discomfort scores than 
those who did not meet criteria for dependence. The authors concluded that these findings 
were similar to those found in studies with adult treatment seekers. The latter finding is also 
compatible with research which suggests two-thirds of cannabis-dependent adolescents 
report experiencing withdrawal (Crowley, Macdonald, Whitmore & Mikulich, 1997).
A common limitation of studies investigating cannabis withdrawal is that the influences of 
other substance withdrawal syndromes are frequently not controlled. For example, although 
over half of the adolescents in the study conducted by Vandrey, Budney, Kamon, et al. 
(2005) were tobacco users, the concurrent effects of nicotine withdrawal were not assessed 
and may have influenced results of the study. This is particularly concerning due to the 
amount of similarity that exists between cannabis and nicotine withdrawal in regards to 
withdrawal discomfort and symptom severity (Budney et al., 2008).
A second limitation of the literature on cannabis withdrawal pertains to the homogeneity of 
study participants; data have primarily been collected from White treatment-seekers. This is 
problematic due to racial differences that have been found in regards to withdrawal 
symptom severity more generally (Brown et al., 2010; Chan et al., 2009). For example, 
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Chan et al. (2009) found Black participants had significantly lower odds of experiencing 
severe alcohol withdrawal compared to non-Black participants. More specifically, Copersino 
et al. (2010) found a higher incidence of four withdrawal symptoms (increased anxiety, 
difficulty sleeping, cravings for cannabis, and depression) among White participants 
compared to Black participants for cannabis withdrawal, but did not control for use level.
The purpose of the present study is to investigate the magnitude of cannabis withdrawal 
symptoms within a racially diverse sample of detained adolescents using archival data. 
These efforts seek to address existing gaps within the literature on cannabis withdrawal by 
assessing the severity of symptoms among a heavy-using, adolescent sample abstinent from 
all substances, including tobacco, controlling for tobacco use, and investigating the impact 
of race on symptom reports. Results are particularly important because of the heavy use 
rates of marijuana in this underserved population of youthful offenders.
Several symptoms have been found to commonly occur during both cannabis and tobacco 
withdrawal syndromes (aggression/anger, anxiety/nervousness, depressed mood, irritability, 
restlessness, and sleep difficulty). Therefore, it is hypothesized that 1) neither marijuana nor 
tobacco will have a significant main effect on these symptoms due to the number of 
adolescents in the present study who use both substances. However, we hypothesize that 2) 
level of marijuana use will have a significant main effect on symptoms common in cannabis 
withdrawal, but not nicotine withdrawal, such as craving to smoke marijuana and strange/
wild dreams (Vandrey, Budney, Moore et al., 2005). Finally, racial differences in the 
reported severity of cannabis withdrawal symptoms are expected; 3) Black adolescents are 
hypothesized to report less severe withdrawal symptoms than non-Black adolescents after 
controlling for substance use prior to detention.
2. Materials and methods
2.1 Participants
As part of admittance to clinical facility care, parents/guardians provided consent for 
adolescents to receive assessment, screening, and treatment. They also consented, and 
adolescents assented, for the information to be de-identified and used in research. All youth 
entering the facility between June 2004 and February 2005 were eligible to complete the 
battery unless staff determined the youth was unable (ill, at risk for violence, etc.), or if staff 
were unable to introduce the assessment program to the youth (no time to introduce because 
of competing duties, short staffed, etc.).
Participants were 93 pre-adjudicated males between 12 and 18 years of age (M = 16.4, SD = 
1.1 years) who were detained at a state juvenile correctional facility in the Northeast (see 
Table 1). Adolescents identified with the following racial/ethnic backgrounds: 45.1% White, 
21.5% Black, 26.88% Hispanic/Latino, and 6.5% other. Approximately half (50.5%) of 
participants reported using cannabis at least once a day during the three months prior to 
detention. Forty-eight percent of participants reported using nicotine almost every day in the 
month prior to detention, and nearly half (51.6%) reported using alcohol at least once a 
month.
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2.2 Measures
As part of the assessment battery, adolescents completed a demographic questionnaire 
containing questions about socio-demographic factors and frequency of substance use prior 
to detention, and the Marijuana Withdrawal Checklist (MWC; Budney et al., 1999). The 
MWC contains symptoms frequently observed during cannabis withdrawal, as well as 
symptoms characteristic of other substance withdrawal syndromes. These additional 
symptoms were included in the development of the measure in order to assess the specificity 
of cannabis withdrawal (Budney et al., 1999).
Because earlier work examining cannabis withdrawal among adolescents utilized a 15-item 
version of the MWC (Vandrey, Budney, Kamon, et al., 2005), the present study focused 
only on the same 15 symptoms known to be reported with some frequency during cannabis 
withdrawal (shakiness/tremulousness, depressed mood, decreased appetite, nausea, 
irritability, sleep difficulty, sweating, craving to smoke marijuana, restlessness, nervousness/
anxiety, increased aggression, headaches, stomach pains, strange/wild dreams, and increased 
anger) to allow for comparison. Each participant was specifically prompted to rate the 
severity of each symptom as he was presently experienceing it on a four-point scale (0 = not 
at all, 1 = mild, 2 = moderate, 3 =severe). This approach may be preferred given the finding 
that retrospective reports of withdrawal symptoms are often inaccurate (Preuss, Watzke, 
Zimmerman, Wong, & Schmidt, 2010). A composite withdrawal discomfort score (WDS) 
was also created by summing each adolescent’s severity ratings for all 15-items. The 
internal reliability of the MWC was high (Cronbach’s alpha= 0.90) and consistent with that 
reported in other studies.
2.3 Procedures
The present study consists of secondary analysis of an archival data set that was collected 
with approval from the detention facility’s research review committee and the IRB of the 
partnering university. Facility workers identified newly detained adolescents to complete the 
battery as part of screening procedures to assist with care of detainees. Adolescents were 
assessed on average 5.7 (SD=12.7) days after entering the facility. A staff member working 
at the facility introduced and familiarized each participant with the computer terminal by 
which the assessments were administered. The assessment battery took approximately 20–45 
minutes to complete. Adolescents then received feedback regarding their results and were 
flagged for further examination by the facility clinical social worker if results were 
suggestive of problematic tobacco, cannabis, or alcohol withdrawal.
In order to assess the effects of both tobacco and marijuana use on the magnitude of 
cannabis withdrawal symptoms, adolescents were classified as heavy or non/less frequent 
users of each substance according to their frequency of use prior to incarceration. Inclusion 
criteria of previous studies on cannabis withdrawal required that participants report heavy 
use of marijuana defined as more than 25 days per month (Budney et al., 2008; Budney, et 
al., 2003). Based on this and the item response options used in the present study to assess 
frequency of marijuana use (see Table 1), adolescents were categorized as heavy users of 
marijuana if they reported smoking at least once a day during the three months prior to 
incarceration; all others were categorized as non/less frequent users. Limited by the how the 
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facility assessed frequency of tobacco use, and to provide for a relatively even split among 
groups, adolescents who reported smoking 16 or more cigarettes a day were categorized as 
heavy tobacco users; all others were categorized as non/less frequent users. Based on the 
above categorizations, about seventeen percent (n=17) of adolescents were classified as both 
heavy marijuana users and heavy tobacco users. Because reports of alcohol use heavy 
enough to anticipate withdrawal symptoms were rare (only 5% of participants reported 
consuming alcohol at least once a day), frequency of alcohol use was not considered as it 
was too low to provide statistical power. In order to assess for racial differences within a 
small sample, racial classifications were defined as Black (n=20) and non-Black (White, 
Hispanic/Latino, Other). Similar definitions were used by Chan et al. (2009).
3. Results
Descriptive statistics regarding the prevalence and severity of withdrawal symptoms were 
computed. The most commonly reported symptoms were sleep difficulty, nervousness/
anxiety, depressed mood, restlessness, increased anger, decreased appetite, headache, and 
sweating. Three of these symptoms (sleep difficulty, depressed mood, and nervousness/
anxiety) were reported to be of at least moderate severity by 30% of participants (see Table 
2).
Age and the number of days between entry and assessment were tested as potential 
covariates. Neither variable was found to be consistently associated with symptom severity 
and therefore, was not included in analyses. Two-way analyses of variance (ANOVAs) were 
performed to determine the effects of both substances on the reported severity of each 
withdrawal symptom and the composite WDS. Contrary to expectations, neither substance 
was found to have a significant main effect on WDS. Analyses revealed a significant main 
effect for level of marijuana use on the reported severity of two withdrawal symptoms: 
craving to smoke marijuana F(1, 91) = 4.20, p = .03; and strange/wild dreams, F(1, 92) = 
5.22, p = .03. A significant main effect for level of tobacco use on the reported severity of 
irritability was also found, F(1, 92) = 4.32, p = .04. Sample means are displayed in Table 3. 
Furthermore, a significant interaction between the level of marijuana and tobacco use on 
sleep difficulty was found, F(1, 92) = 4.19, p = .04. Simple main effects analysis showed 
that adolescents reporting heavy tobacco use prior to detention reported significantly more 
difficulty sleeping when marijuana use was relatively low (p = .01), but no effect for level of 
tobacco use was found when marijuana use was heavy (p = .76).
Next, race was included in the analyses to determine if racial differences existed in the 
reported severity of withdrawal symptoms after accounting for frequency of substance use. 
As expected, significant main effects for race were found. Black adolescents had 
significantly lower WDS scores (F(1, 92) = 6.96; p = .01), reported significantly less severe 
depressed mood (F(1, 92) = 6.62, p = .01), sleep difficulty (F(1, 92) = 5.41, p < .05), 
nervousness/anxiety (F(1, 92) = 5.54, p = .02), and strange/wild dreams (F(1,92) = 4.06, p 
< .05) than non-Black adolescents. Sample means are displayed in Table 3.
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4. Discussion
The present study extends the literature on cannabis withdrawal by exploring the magnitude 
of cannabis withdrawal symptoms within a racially diverse sample of detained adolescents. 
Due to the frequency with which several symptoms are commonly reported during both 
cannabis and nicotine withdrawal syndromes, and the number of adolescents who reported 
use of both substances prior to detention, it was expected that neither substance would have 
a significant main effect on the reported severity of aggression, anger, anxiety/nervousness, 
depressed mood, irritability, restlessness, or sleep difficulty. Results supported this 
hypothesis with one exception. Level of tobacco use was found to produce a significant 
main effect on the reported severity of irritability; heavy tobacco users reported 
experiencing more severe irritability than non/less frequent tobacco users. This finding 
conflicts with earlier research which found a greater prevalence of irritability among 
cannabis abstainers compared to tobacco abstainers (Budney et al., 2008). This contradictory 
finding may result from the small sample size. It may also suggest that previous findings on 
cannabis withdrawal symptoms produced misleading results because tobacco cessation was 
not simultaneously controlled.
As expected, a significant main effect for level of marijuana use on the reported severity of 
craving to smoke marijuana and strange/wild dreams was found. More specifically, heavy 
marijuana users reported experiencing more severe cravings to smoke marijuana and more 
severe strange/wild dreams than non/less frequent marijuana users. These findings are 
consistent with previous research which found these symptoms to be characteristic of 
cannabis, but not nicotine withdrawal (Vandrey, Budney, Moore, et al., 2005). Furthermore, 
these findings provide further support for the existence of withdrawal symptoms specific to 
the cessation of heavy marijuana use as experienced by adolescents.
Overall, race was found to have a significant impact on more symptom reports than the level 
of use for either substance. Black adolescents had significantly lower withdrawal discomfort 
scores and experienced less severe depressed mood, difficulty sleeping, nervousness/
anxiety, and strange/wild dreams than non-Black adolescents. These findings are consistent 
with previous research which found lower subjective withdrawal scores (Brown et al., 2010) 
and incidence of depression, anxiety, and difficulty sleeping (Copersino et al., 2010) for 
Black compared to White participants among adult cannabis users. Reasons for these racial 
differences remain unclear and warrant further research. Genetic variations may influence 
the process by which substances are metabolized in the body (Chan et al., 2009, Thomasson, 
Crabb, Edenberg, & Li, 1993), and impact withdrawal syndromes. Furthermore, these 
differences may reflect a hesitation among African Americans to report unpleasant 
experiences (Kosten & Rayford, 1995).
Due to several methodological limitations, these findings must be interpreted with caution. 
As previously mentioned, the sample size was small although this is common among studies 
on cannabis withdrawal (Budney et al., 1999; Budney et al., 2003; Vandrey et al., 2008; 
Vandrey, Budney, Kamon, et al., 2005). Furthermore, the group of non-Black adolescents 
was ethnically diverse. Research studies with larger sample sizes and statistical power are 
needed to determine the severity of cannabis withdrawal symptoms between substance use 
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and racial and ethnic groups more precisely. Adolescents were assessed at varying times 
after entrance to the facility. However, peak effects from cannabis withdrawal have been 
found to occur between days 2–6 of abstinence and most effects last through day 14 
(Budney et al., 2003). Ninety-four percent of participants in the current study were assessed 
within this period. Moreover, it is rare that an adolescent enters detention from another 
controlled environment, therefore, it is unlikely the youth experienced forced abstinence 
prior to being detained. Furthermore, number of days between entry and assessment was 
generally not found to be a significant predictor of symptom severity when investigated for 
use as a covariate. Although level of marijuana and tobacco use was statistically controlled, 
use of additional substances was not. Note that use of other substances (e.g., alcohol) heavy 
enough to prompt withdrawal was rare. Another limitation of the current study is that well-
controlled laboratory methods were not used. However, findings are likely more 
ecologically valid and consistent with what providers confront in applied settings with 
heavy-using adolescents. Similarly, the extent to which adolescents could be classified 
according to their level of substance use (heavy vs. non/less frequent) was limited by the 
questions the facility utilized pertaining to use frequency (e.g. tobacco users were asked if 
they smoked 0–15, 16–25, or 26+ cigarettes per day). Although the classifications used 
allowed for the assessment of withdrawal symptom severity among the heaviest-using 
adolescents, future research is needed to more systematically control for the confounding 
effects of tobacco withdrawal and determine the level of marijuana use that can be expected 
to lead to withdrawal after cessation of use. Lastly, the generalizability of the findings is 
likely limited to detained male adolescents who may be more likely to report experiencing 
such symptoms as depression, anxiety, sleep difficulty, etc. due to situational factors related 
to being detained. This may also explain why differences in withdrawal discomfort scores 
were not found between substance use groups. This finding may also have been influenced 
by the proportion of adolescents (17%) who were heavy users of both marijuana and 
tobacco.
Despite these limitations, our findings may have significant clinical implications for 
providers in juvenile detention facilities. Providers may be encouraged to assess adolescents 
for substance withdrawal syndromes upon entry given the high and heavy rates of substance 
use (e.g., marijuana, tobacco) among detained adolescents. Symptoms of withdrawal 
syndromes may mimic symptoms of various psychiatric disorders (e.g., depressed mood, 
nervousness/anxiety, irritability, sleep difficulty). Assessment of withdrawal syndromes may 
prevent inaccurate mental health diagnoses and unnecessary psychotropic medications. 
Instead, proper medical and/or behavioral interventions and additional support could be 
employed to assist adolescents presenting with problematic cannabis and/or tobacco 
withdrawal. In addition to informing clinical care, these results are suggestive for future 
research that is better controlled, particularly among such high-using, understudied 
adolescent populations.
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Table 1
Participant characteristics (N=93)
Demographics
    Mean (SD) age in years 16.4 (1.2)
    % Male 100
    % Black 21.5
    % White 45.1
    % Hispanic/Latino 26.9
    % Other race/ethnicity 6.5
Substance use
Marijuana (% past 3 months)
    Never used 10.5
    Less than once a month 12.6
    1–2 times a month 6.3
    3–4 times a month 11.6
    3–4 times a week 9.5
    Once a day 7.5
    A few times a day 43.0
Tobacco (% per day)
    Non-smokers 37.9
    0–15 32.6
    16–25 21.5
    26+ 8.6
Alcohol (% past 3 months)
    Never used 15.8
    Less than once a month 32.6
    1–2 times a month 22.1
    3–4 times a month 18.9
    3–4 times a week 5.3
    Once a day 3.2
    A few times a day 2.1
Withdrawal discomfort score 24.9 (9.4)
Mean (SD) number of days between
    Entry & Assessment 5.7 (12.7)
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Table 2
Percentage of participants reporting each MWC item by severity rating
Mild rating ≥ 1 Moderate rating ≥ 2 Severe rating ≥ 3
Mood
    Depressed mood 53.76 36.56 15.05
    Increased anger 35.87 22.83 11.96
    Irritability 40.86 16.13 9.68
    Nervousness/anxiety 55.91 30.1 10.75
Behavioral
    Craving 20.65 14.13 6.52
    Decreased appetite 34.40 21.90 12.90
    Increased aggression 21.74 15.22 4.35
    Restlessness 49.46 25.80 10.75
    Sleep difficulty 66.67 39.79 25.81
    Strange dreams 25.81 16.13 6.45
Physical
    Headache 33.33 16.13 3.23
    Nausea 19.36 9.68 1.08
    Shakiness 24.74 15.06 3.23
    Stomach pains 30.10 15.05 4.30
    Sweating 34.41 16.13 10.75
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Table 3
Sample means by substance and race.
95% Confidence Level
Mean Std. Error Lower Bound Higher Bound
Tobacco Use
Irritability
    Non/less frequent 1.53 .12 1.29 1.76
    Heavy 1.98 .18 1.62 2.34
Marijuana Use
Craving marijuana
    Non/less frequent 1.28 .15 .99 1.57
    Heavy 1.69 .13 1.42 1.95
Strange/wild dreams
    Non/less frequent 1.31 .15 1.02 1.61
    Heavy 1.77 .14 1.50 2.04
Black
Withdrawal Discomfort Score
    No 26.88 1.12 24.65 29.11
    Yes 18.47 2.99 12.53 24.41
Depressed mood
    No 2.24 .14 1.97 2.52
    Yes 1.23 .37 .49 1.96
Sleep difficulty
    No 2.50 .14 2.22 2.78
    Yes 1.68 .38 .92 2.43
Nervousness/anxiety
    No 2.14 .13 1.89 2.39
    Yes 1.29 .34 .62 1.96
Strange/wild dreams
    No 1.66 .11 1.44 1.87
    Yes 1.04 .29 .48 1.69
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